Breast Density Clinical Trial
Official title:
A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose-Response Study of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
This is a randomized, double-blinded, placebo-controlled dose-response efficacy study of oral (Z)-endoxifen in premenopausal women with measurable breast density. There will be 5 in-clinic visits (Screening, Day 1, Months 1, 3 and 6) and 3 self-report visits (Months 2, 4 and 5). Standard of care mammograms will be used for the screening mammogram as well as the 24-month follow up visit.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05900544 -
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
|
N/A | |
| Active, not recruiting |
NCT03920098 -
Chilean Maternal & Infant Cohort Study II (CHiMINCs-II)
|
||
| Recruiting |
NCT05181059 -
DLSCT for Breast Cancer Detection in Women With Dense Breasts
|
||
| Completed |
NCT03029286 -
ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2
|
N/A |